Glass House Brands Inc. (GLASF) Event May 22, 2024, 10:02 UTC 36 1 comments (99% Neutral) Glass House Brands Inc. (GLASF) Files Form 6-K Comment Full text
Paratek Pharmaceuticals Inc (was acquised by Gurnet Point Capital ("Gurnet Point") and Novo Holdings A/S ("Novo Holdings") on 21/09/2023) (PRTK) Event Sept. 18, 2023, 16:49 UTC 53 1 comments (35% Negative) PARATEK PHARMACEUTICALS, INC. (PRTK) Announces Business Combination Comment Full text
Passage Bio Inc (PASG) Event Feb. 24, 2023, 12:00 UTC 47 1 comments (10% Negative) PASSAGE BIO, INC. (PASG) Announces Delay in patients Trials for GM1 gangliosidosis (GM1) Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Cytokinetics Inc (CYTK) Event Dec. 12, 2022, 04:00 UTC 444 0 comments Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND Comment Full text
Cytokinetics Inc (CYTK) Event Dec. 12, 2022, 04:00 UTC 244 0 comments Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Comment Full text
Equillium Inc. (EQ) Event Dec. 11, 2022, 02:06 UTC 235 0 comments Equillium - Equillium Corporate Presentation Comment Full text
Exact Sciences Corporation (EXAS) Event Dec. 09, 2022, 18:05 UTC 233 0 comments Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients Comment Full text
Cytokinetics Inc (CYTK) Event Dec. 09, 2022, 17:01 UTC 239 0 comments Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil Comment Full text
QuantumSi Inc (QSI) Event Dec. 08, 2022, 16:01 UTC 246 0 comments Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board Comment Full text
Cytokinetics Inc (CYTK) Event Dec. 08, 2022, 15:30 UTC 239 0 comments Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND Comment Full text